a review of recent in vitro studies with cefoxitin and parenterally administered cephalosporins indicates that cefoxitin is the most active compound against the b. fragilis group and is least active against clostridium species other than c. perfringens .
C3536856
cephalosporins
C0007557
cefoxitin